Larimar Therapeutics News

Larimar Therapeutics Analyst Ratings

BenzingaMay 31 11:44 ET

Buy Rating Affirmed for Larimar Therapeutics as FDA Accelerates Nomlabofusp's Path in START Pilot Program

TipRanksMay 30 19:25 ET

Buy Rating on Larimar Therapeutics: Navigating FDA Approval With Promising FA Treatment

TipRanksMay 30 18:45 ET

Larimar Therapeutics Analyst Ratings

BenzingaMay 22 13:48 ET

Larimar Therapeutics Analyst Ratings

BenzingaMay 21 12:35 ET

Buy Rating Reaffirmed for Larimar Therapeutics Post FDA Clinical Hold Lift and Positive Drug Trial Trajectory

TipRanksMay 21 12:05 ET

Optimistic Buy Rating for Larimar Therapeutics Backed by Positive Phase 2 Results and Strategic FDA Discussions

TipRanksMay 14 04:38 ET

Buy Rating for Larimar Therapeutics Backed by Strong Clinical and Financial Outlook

TipRanksMay 10 00:56 ET

Buy Rating Affirmed for Larimar Therapeutics Amid Promising Phase II Data and Strategic OLE Study for FA Treatment

TipRanksMay 9 16:05 ET

Larimar Therapeutics Analyst Ratings

BenzingaApr 3 09:15 ET

Buy Rating Justified: Larimar Therapeutics' Advancements Towards FDA Approval for FA Drug Nomlabofusp

TipRanksMar 15 16:15 ET

Larimar Therapeutics Analyst Ratings

BenzingaMar 15 10:35 ET

JMP Securities Reiterates Market Outperform on Larimar Therapeutics, Maintains $25 Price Target

BenzingaMar 15 10:37 ET

Larimar Therapeutics Analyst Ratings

BenzingaMar 12 10:06 ET

Buy Rating on Larimar Therapeutics Backed by Promising Drug Progress for Friedreich's Ataxia

TipRanksMar 12 08:25 ET

Analysts Are Bullish on These Healthcare Stocks: ACADIA Pharmaceuticals (ACAD), Larimar Therapeutics (LRMR)

TipRanksMar 12 00:40 ET

Buy Rating Affirmed: Larimar Therapeutics' Nomlabofusp Shows Potential in Friedreich's Ataxia Treatment

TipRanksFeb 20 19:55 ET

Larimar Therapeutics Analyst Ratings

BenzingaFeb 13 09:15 ET

Buy Rating Affirmed: Larimar Therapeutics' Promising Drug Advances on Regulatory and Efficacy Fronts

TipRanksFeb 13 04:59 ET

Citigroup Upgrades Larimar Therapeutics to Buy, Predicts 284% Surge

InvestingNov 18, 2023 09:54 ET